88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Sisram Medical Delivers Solid 2026 Interim Results Injectables Business Fuels Rapid Growth as APAC Drives International Revenue Expansion ... 2026-08-19T Biotechnology Cosmetics & Personal Care Medical/Pharmaceuticals
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum SHANGHAI , Aug. 19, 2026 /PRNewswire/ -- Hengrui Pharma ("Hengrui" or "the Company") today announced its financial results for the first half of 2026. During the reporting period, ... 2026-08-19T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion HONG KONG , Aug. 19, 2026 /PRNewswire/ -- Sino Biopharmaceutical Limited (HKEX: 01177), a leading innovation-driven pharmaceutical company in China, announced the launch of its new global brand, SBP ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care Patients from Australia, India, Indonesia, South Korea and Singapore gathered at Edwards Lifesciences' annual APAC Patient Experience event to share their stories and help advance more patient-centered ... 2026-08-19T Health Care/Hospital Medical/Pharmaceuticals
NORROY BIOSCIENCE Granted FDA Breakthrough Therapy and Fast Track Designations for Kidney Cancer Imaging Product WUXI, China , Aug. 19, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY) , a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that the U.S. Food and ... 2026-08-19T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Strong growth from Vyepti® and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026 VALBY, Denmark , Aug. 19, 2026 /PRNewswire/ -- Key highlights ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Announces Interim Results for First Half of 2026 SHANGHAI , Aug. 19, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 Blenrep, a first-in-class anti-BCMA ADC, could transform treatment ... 2026-08-19T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit SHANGHAI and HONG KONG , Aug. 19, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CARsgen Therapeutics Announces 2026 Interim Results SHANGHAI , Aug. 19, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2026 Interim Re ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals